Related Experiment Video
Updated: Dec 22, 2025

Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
Biomedical Research in Times of Emergency: Lessons From History
Deborah Doroshow1, Scott Podolsky2, Justin Barr3
1Icahn School of Medicine at Mount Sinai, New York, New York (D.D.).
Insights
Despite rapid COVID-19 research, history shows early results require caution. Continued scientific investment is crucial for understanding and treating the novel coronavirus disease.
Area of Science:
- Biomedical research
- Epidemiology
- Infectious disease
Background:
- The COVID-19 pandemic has caused global devastation, necessitating urgent scientific and financial investment.
- Historical precedents, like the Manhattan Project and polio vaccines, demonstrate rapid research can yield significant scientific accomplishments.
- However, historical examples also highlight potential pitfalls of pressurized research, including ethical breaches and false promises.
Observation:
- The global response to COVID-19 has involved substantial funding and numerous clinical trials for understanding, prevention, and treatment.
- Past public health crises have seen both remarkable scientific progress and cautionary tales of research failures and ethical lapses.
- Early findings, such as those concerning hydroxychloroquine for COVID-19, warrant careful consideration due to the evolving understanding of the disease.
Findings:
- National emergencies can accelerate scientific breakthroughs but also carry risks.
- Pressurized research environments may lead to premature conclusions or ethical compromises.
- The COVID-19 pandemic mirrors historical patterns of rapid scientific mobilization alongside potential research challenges.
Implications:
- Continued, prioritized funding and attention for COVID-19 research are essential.
- Historical analysis underscores the need for critical evaluation of early scientific results.
- A balanced approach is required, acknowledging both the potential for rapid advancement and the importance of rigorous scientific integrity in addressing the COVID-19 pandemic.
Abstract:
Coronavirus disease 2019 (COVID-19) has sickened millions, killed hundreds of thousands, and utterly disrupted the daily lives of billions of people around the world. In an effort to ameliorate this devastation, the biomedical research complex has allocated billions of dollars and scientists have initiated hundreds of clinical trials in an expedited effort to understand, prevent, and treat this disease. National emergencies can stimulate significant investment of financial, physical, and intellectual resources that catalyze impressive scientific accomplishments, as evident with the Manhattan Project, penicillin, and the polio vaccines in the 20th century. However, pressurized research has also led to false promises, disastrous consequences, and breaches in ethics. Antiserum in the 1918 flu epidemic, contaminated yellow fever vaccines in World War II, and unethical human experimentation with mustard gas offer just a few cautionary exemplars. It is critical to continue biomedical research efforts to address this pandemic, and it is appropriate that they receive priority in both attention and funding. But history also demonstrates the importance of treating early results-such as those associated with hydroxychloroquine-with caution as we only begin to understand the biology, epidemiology, and potential target points of COVID-19.
Related Concept Videos
Steps in Outbreak Investigation
Ethics in Research
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Overview of Biostatistics in Health Sciences
Bias in Epidemiological Studies
Microorganisms in Medicine and Therapeutics

